Literature DB >> 9131422

Purinoceptor-mediated regulation of the renal microvasculature.

E W Inscho1.   

Abstract

1. Recent evidence supports the contention that numerous paracrine factors are released into the intrarenal interstitial environment where they can influence renal microvascular and tubular function. Studies have shown that P1 and P2 purinoceptor activation by adenosine and ATP, respectively, can selectively evoke alterations in renal microvascular diameter. 2. Vasoconstrictor responses to extracellular ATP, which are almost exclusively preglomerular, are biphasic, develop rapidly and are rapidly reversible. ATP-mediated afferent arteriolar vasoconstriction is largely dependent on the influx of extracellular calcium and the sustained vasoconstriction is maintained by calcium influx through voltage-dependent L-type calcium channels. 3. Microvascular responses to adenosine include vasoconstriction at low concentrations and vasodilation at higher concentrations. Adenosine elicits a vasoconstrictor response which develops more slowly than responses to ATP and the vasoconstriction is elicited from both the preglomerular and postglomerular arterioles. 4. Studies were performed to evaluate the possible involvement of P2 purinoceptor activation in the renal vascular autoregulatory response. Inactivation of P2 receptor-dependent preglomerular microvascular responses by purinoceptor desensitization or purinoceptor saturation completely abolished autoregulatory adjustments in afferent arteriolar calibre. 5. These studies demonstrate that the renal microvasculature is responsive to purinoceptor activation. Furthermore, the data support an important role for the involvement of intrarenal P2 receptors in the regulation of renal haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9131422     DOI: 10.1111/j.1474-8673.1996.tb00059.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  5 in total

1.  Maintained tubuloglomerular feedback responses during acute inhibition of P2 purinergic receptors in mice.

Authors:  Jurgen Schnermann
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-08

Review 2.  Adenosine receptors and the kidney.

Authors:  Volker Vallon; Hartmut Osswald
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Extracellular 2,3-cyclic adenosine monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth [corrected].

Authors:  Edwin K Jackson; Jin Ren; Delbert G Gillespie; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-06-01       Impact factor: 10.190

4.  Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.

Authors:  Yong-Chul Kim; Emidio Camaioni; Airat U Ziganshin; Xiao-Duo Ji; Brian F King; Scott S Wildman; Alexei Rychkov; Joshua Yoburn; Heaok Kim; Arvind Mohanram; T Kendall Harden; José L Boyer; Geoffrey Burnstock; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1998-10-01       Impact factor: 4.360

Review 5.  Adenosine and kidney function: potential implications in patients with heart failure.

Authors:  Volker Vallon; Cindy Miracle; Scott Thomson
Journal:  Eur J Heart Fail       Date:  2008-02-01       Impact factor: 15.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.